News overview

Nwo logo
19 June 2020
Two Oncode Investigators awarded the highest distinction in Dutch Science
Two Oncode Investigators will receive the highest awards in science. Professor Sjaak Neefjes (LUMC) will be awarded the Spinoza Prize and professor Ton Schumacher (NKI) will receive the Stevin Prize. Each laureate will receive 2.5 million euros, which they can spend on scientific research and activities related to knowledge utilisation.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Oncode about icon copy 13
18 June 2020
Oncode Oncology Bridge Fund appoints Investment Advisory Committee
The Oncode Oncology Bridge Fund provides early stage financing to support the creation and growth of new enterprises based on highly innovative science performed by researchers at the Oncode Institute. We are proud to announce that the Bridge Fund has appointed its Investment Advisory Committee (IAC). The role of the IAC is to review and make recommendations on investment proposals presented by the Fund Managers.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
IT
27 May 2020
New facilities available for Oncode researchers
We are pleased to announce that three facilities are now open to the whole Oncode research community. The goal of Oncode Institute is to translate the results of ground-breaking fundamental research into the clinic faster, in order to improve the chances of cancer patients. Instead of competition between scientists, Oncode encourages collaboration. Investing in facilities which can be used by all Oncode researchers, is one of the ways in which Oncode wants to contribute to breakthroughs in cancer research.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Huib ovaa jpg
22 May 2020
In Memoriam: Professor Huib Ovaa
On the 19th of May 2020, our dear colleague Professor Dr. Huib Ovaa passed away from prostate cancer. In the past year, Huib has undergone a variety of treatments, and has done so with his usual optimism. He continued to work as much as possible and tried to keep the burden of his fight against cancer away from the people around him. Huib was 46 years of age.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Oncode top 50
15 May 2020
Oncode Institute is in Top 50 NPO/NGOs ranked by Nature Index
We are honoured to announce that Nature Index included Oncode Institute in its Top 50 NPO/NGO institutions in cancer research worldwide. Every year, Nature Index publishes its Cancer supplement, featuring a list of the most prominent institutes and academic, healthcare, NPO/NGO, government and corporate institutions working in cancer research.
Bianca-OliviaNita
Open Science
30 April 2020
Insight into Making Scientific Findings Publicly Available
Preprint servers like BioRxiv or MedRxiv are tools that can be combined with traditional peer reviewed journals to increase impact and visibility. Until 2019, only around 5% of publications by Oncode Investigators were shared via a preprint server before being published in a peer reviewed journal, whether OA or subscription. We spoke to Oncode Investigator Lude Franke (UMCG) about how publishing on BioRxiv strongly impacted his research.
Bianca-OliviaNita
Oncode Icons Square 01
30 April 2020
Oncode Investigator Rene Bernards elected to National Academy of Sciences
Oncode Institute is proud to announce that Oncode Investigator Rene Bernards (NKI) has been elected as a member of the prestigious National Academy of Science (NAS) in the United States.
Bianca-OliviaNita
Mentoring Icon
24 April 2020
Dirk Pollet joins Oncode Oncology Bridge Fund as Entrepreneur in Residence
Following Dr. Markwin Velders and Dr. Allard Kaptein joining the Oncode Oncology Bridge Fund as Entrepreneurs in Residence this February, we are happy to announce that Dr. Dirk Pollet now joined the Oncode Oncology Bridge Fund’s team of experienced entrepreneurs.
Bianca-OliviaNita
Vlinder
27 March 2020
In memoriam: Anjo van Heijst
We received the sad news that Anjo van Heijst passed away on March 23. Anjo was one of the first patient representatives of Oncode’s Clinical Advisory Board. With her knowledge and enthusiasm, she contributed immensely to the development of our clinical programmes. She was also a driving force behind Werkgroep Darmkanker, a platform for patients with colon cancer and their loved ones.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Clinic
20 March 2020
Two New Clinical Proof-of-Concept Projects Funded by Oncode Institute
Oncode Institute aims to link fundamental and clinical research to enable efficient translation of promising findings into novel diagnostic methods and clinical treatment strategies. We are pleased to announce that the 9th and 10th grant within the Clinical Proof of Concept programme have been awarded.
Bianca-OliviaNita
Compounds
17 March 2020
The Oncode Compound Library: find new therapeutic applications that others missed
Oncode’s newly acquired Drug Repurposing Library is now available to all Oncode researchers, through the Drug Repurposing Programme. The library encompasses more than 6.000 unique compounds in different stages of clinical development. Each of them has extensively curated annotations, including details about commercial sources. Besides access to the library, Oncode will provide the technical infrastructure and expertise needed to perform complex compound screens.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Pmc image
13 March 2020
New research model: mini-tumors of the kidney
Exciting new research from Oncode Investigator Jarno Drost (Princess Máxima Center) on childhood kidney tumors. His group succeeded in establishing organoid cultures, derived from a variety of different childhood kidney tumors, which can be used to study the biology of non- Wilms tumors as well as to test new medication. These results have been published in Nature Communications.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.